Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT06710756 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Gastric Cancer
Esophageal Cancer
Colorectal Cancer
Ovarian Cancer
Head and Neck Cancer
Sarcoma
Mesothelioma

Interventions

DRUG: [203Pb]Pb-PSV359
DRUG: [212Pb]Pb-PSV359

Sponsor

Perspective Therapeutics